| Schedule of the calculation of basic and diluted earnings per share |
The following table reflects the calculation of basic and diluted earnings per share (in thousands, except per share amounts):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended June 30, |
|
|
2023 |
|
2022 |
|
2021 |
Earnings per share – basic: |
|
|
|
|
|
|
|
|
|
Net earnings, including noncontrolling interest |
|
|
285,442 |
|
|
263,099 |
|
|
139,585 |
Less net earnings (loss) attributable to noncontrolling interest |
|
|
179 |
|
|
(8,952) |
|
|
(825) |
Net earnings attributable to Bio-Techne |
|
$ |
285,263 |
|
$ |
272,051 |
|
$ |
140,410 |
Income allocated to participating securities |
|
|
(70) |
|
|
(121) |
|
|
(86) |
Income available to common shareholders |
|
$ |
285,193 |
|
$ |
271,930 |
|
$ |
140,324 |
Weighted-average shares outstanding – basic |
|
|
157,179 |
|
|
156,874 |
|
|
154,986 |
Earnings per share – basic |
|
$ |
1.81 |
|
$ |
1.73 |
|
$ |
0.91 |
|
|
|
|
|
|
|
|
|
|
Earnings per share – diluted: |
|
|
|
|
|
|
|
|
|
Net earnings, including noncontrolling interest |
|
$ |
285,442 |
|
$ |
263,099 |
|
$ |
139,585 |
Less net earnings (loss) attributable to noncontrolling interest |
|
|
179 |
|
|
(8,952) |
|
|
(825) |
Net earnings attributable to Bio-Techne |
|
|
285,263 |
|
|
272,051 |
|
|
140,410 |
Income allocated to participating securities |
|
|
(70) |
|
|
(121) |
|
|
(86) |
Income available to common shareholders |
|
$ |
285,193 |
|
$ |
271,930 |
|
$ |
140,324 |
Weighted-average shares outstanding – basic |
|
|
157,179 |
|
|
156,874 |
|
|
154,986 |
Dilutive effect of stock options and restricted stock units |
|
|
4,676 |
|
|
7,240 |
|
|
6,946 |
Weighted-average common shares outstanding – diluted |
|
|
161,855 |
|
|
164,114 |
|
|
161,932 |
Earnings per share – diluted |
|
$ |
1.76 |
|
$ |
1.66 |
|
$ |
0.87 |
|